MO

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 1998, for Philip Morris Companies Inc. (Note: The input metadata listed "Altria Group," but the filing text explicitly identifies the registrant as Philip Morris Companies Inc.). The Company operates primarily in tobacco, food, beer, and financial services segments. The report highlights significant ongoing litigation regarding tobacco health effects and health care cost recovery, as well as the impact of currency fluctuations and commodity costs.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Operating revenues increased 2.2% for the nine months and 2.7% for the quarter, driven primarily by tobacco operations. Underlying revenues (excluding divestitures) increased 3.2%.
• Profitability: Net earnings rose 1.7% for the nine months and 40.8% for the quarter. The quarterly surge was largely due to a significant reduction in litigation settlement charges compared to the prior year.
• Settlement Charges: The Company recorded $1.116 billion in settlement charges for the nine months of 1998 (including $111 million in Q3) related to "Most Favored Nation" clauses in state health care cost recovery settlements. This compares to $812 million in settlement charges in Q3 1997 alone.
• Currency Impact: A strengthening U.S. dollar reduced operating revenues by $2.2 billion and operating income by $331 million for the nine-month period.
• Segment Performance:
  • Tobacco: Domestic revenues rose 11.8% (nine months) due to pricing, though volume declined. International revenues rose 3.8%.
  • Food: North American food revenues increased 1.1%, while international food revenues decreased 9.2% due to currency and divestitures.
  • Beer: Revenues decreased 2.1% due to lower volume.

Guidance, Outlook, Risks, and Unusual Items

• Litigation Risks: The Company faces substantial uncertainty regarding tobacco-related litigation. As of November 1, 1998, there were approximately 450 individual smoking/health cases, 65 class actions, and 140 health care cost recovery cases pending. A proposed Master Settlement Agreement with states could require the industry to pay over $206 billion through 2025, with an immediate payment of $2.4 billion (PM Inc.'s share estimated at 68%).
• Regulatory Environment: Risks include potential federal tobacco legislation, FDA regulation challenges (though a court recently ruled against FDA jurisdiction), and increasing excise taxes. The Company notes that future tax increases could materially adversely affect volume and operating income.
• Year 2000 (Y2K) Issue: The Company estimates total costs for Y2K remediation at approximately $550 million, with $250 million already spent. While a program is underway, the Company acknowledges potential disruptions from third-party failures.
• Dividends: The Board approved a 10% increase in the quarterly dividend to $0.44 per share, resulting in an annualized rate of $1.76.
• Unusual Items: Results were impacted by $327 million in charges for voluntary early retirement and separation programs and a $10 million severance charge in Q3. The 1997 period included a $103 million gain on the sale of real estate operations.

Investor Verification Checklist

• Verify the status and potential financial impact of the proposed Master Settlement Agreement with state attorneys general regarding health care cost recovery.
• Monitor the outcome of the FDA jurisdiction litigation and any new federal tobacco legislation.
• Assess the progress of the Year 2000 (Y2K) remediation program and the readiness of key business partners.
• Review the trajectory of domestic cigarette volume declines versus price increases to gauge long-term revenue sustainability.
• Confirm the Company's ability to fund future litigation payments and settlement obligations without compromising liquidity or credit ratings.